Jessie Hellmann
- Indexed articles, last 90 days
- 4
- Latest publication
- Aug 5, 2026
- Outlet visibility, for spokesman.com
- Top 100K sites
- Earliest in this view
- Jul 15, 2026
Latest articles
Opt-out testing for hepatitis C seen as key to fighting disease (opens the original)
Read excerpt
LONDON — At King’s College Hospital in the south of London, anyone who has blood drawn in the emergency department is automatically tested for hepatitis B and C. Posters throughout the facility inform patients that the screening is routine, part of a new approach helping find and treat thousands of people who might otherwise never know they have the viruses, which can be fatal if left untreated. “We pick up a lot of people who would never have actively accessed this kind of testing themselves —
Competing bills aim for elusive changes to drug discount program (opens the original)
Read excerpt
A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to reshape the program amid escalating tensions between hospitals and drugmakers. Lawmakers in both chambers have rolled out, or are planning to soon introduce, fresh proposals to alter the 340B program, which requires drug manufacturers sell deeply discounted drugs to safety net providers, including some hospitals and community health centers that serve large numbers of low-i
HHS research agency ends funding for dozens of health studies (opens the original)
Read excerpt
The Trump administration terminated dozens of health research grants this week, telling grantees it is shifting priorities to issues like the “overmedication of children” and autism, according to a prominent research organization. The cuts hit projects at the Agency for Healthcare Research and Quality, many of them multiyear awards that had already been indefinitely delayed. At least 67 grants — a significant share of the agency’s portfolio — have been canceled as of Friday, according to Academy
Bipartisan bill to eliminate hepatitis C unveiled in House (opens the original)
Read excerpt
A bipartisan pair of House members is introducing legislation aimed at treating millions of Americans of a deadly-but-curable liver disease, the culmination of a yearslong push from public health advocates. The bill, sponsored by Reps. Mariannette Miller-Meeks, R-Iowa and Diana DeGette, D-Colo., would create a national hepatitis C elimination program to expand testing and treatment especially for people least likely to access it, including those who are incarcerated, uninsured, low-income, or r
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For spokesman.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.